The Analysis for Termination of Treatment and Satisfaction in Traffic Accident Patient

NCT04167930 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 682

Last updated 2022-08-10

No results posted yet for this study

Summary

Data of one hospital will be used to find out the patient's satisfaction with the treatment, analyze the factors effecting on the treatment termination.

Also, plan to see if there is a correlation between prognosis according to the seriousness of the accident. In addition, investigators want to find out the participants' perception of car insurance and their satisfaction with traditional Korean medicine treatment.

Conditions

  • Accidents, Traffic
  • Whiplash Injuries

Interventions

OTHER

electronic medical record(EMR) Data and patient survey

1. Retrospective Data Collection (1) Neck Disability Index (NDI), Oswestry Low Back Disability Index(ODI), euroqol-5 dimension(EQ-5D) scores during hospitalization (2) symptom onset date, symptom onset motive, past history, accident occurrence date, accident treatmen termination agreement date, etc. 2. Question items (consistent with the case record) according to the purpose of the investigation (1) General: Demographic sociological characteristics (gender, age, occupation, income, etc.) (2) Matters concerning the correlation between traffic accident agreements and symptoms

Sponsors & Collaborators

  • Korea Health Industry Development Institute

    collaborator OTHER_GOV
  • Jaseng Medical Foundation

    lead OTHER

Principal Investigators

  • In-Hyuk Ha · Jaseng Medical Foundation

Eligibility

Min Age
19 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-10-01
Primary Completion
2019-11-30
Completion
2020-01-31

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04167930 on ClinicalTrials.gov